Osteopore Ltd. (AU:OSX) has released an update.
Osteopore Ltd., a front-runner in regenerative medicine, has announced the extension of its S$1,000,000 bridging loan maturity date to May 1, 2025, improving repayment terms to a flat 3% monthly interest rate and maintaining the option for early repayment. CEO Dr. Lim Yujing emphasizes this strategic move will reduce loan costs and support the company’s growing commercial momentum. Shareholders are acknowledged for their support in strengthening the company’s capital foundation.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.
